Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive declineRik Ossenkoppele, Oskar Hansson, Alexa Pichet Binette et al.|Nature Medicine|2022Cited by 483
<sup>18</sup>F‐flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter studyDaniel R. Schonhaut, Gil D. Rabinovici, Murray Grossman et al.|Annals of Neurology|2017Cited by 175
Plasma p‐tau231, p‐tau181, <scp>PET</scp> Biomarkers, and Cognitive Change in Older AdultsPierre‐François Meyer, Sylvia Villeneuve, Nicholas J. Ashton et al.|Annals of Neurology|2022Cited by 99
Cross-sectional associations between [18F]GTP1 tau PET and cognition in Alzheimer's diseaseEdmond Teng, Robby M. Weimer, Michael E. Ward et al.|Neurobiology of Aging|2019Cited by 46
Baseline [18F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer’s diseaseEdmond Teng, Robby M. Weimer, Paul T. Manser et al.|Alzheimer s Research & Therapy|2021Cited by 33